June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Response of ARPE-19 cybrids of European and African origin to high glucose and bevacizumab.
Author Affiliations & Notes
  • Sean W Tsao
    Ophthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Abdul Sami Memon
    Ophthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Sina Abedi
    Ophthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Mohammad Riazi Esfahani
    Ophthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Mohamed Mohamed
    Ophthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Sonali R Nashine
    Ophthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Marilyn Chwa
    Ophthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Cristina M Kenney
    Ophthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Baruch D Kuppermann
    Ophthalmology, Gavin Herbert Eye Institute, Irvine, California, United States
  • Footnotes
    Commercial Relationships   Sean Tsao, None; Abdul Sami Memon, None; Sina Abedi, None; Mohammad Riazi Esfahani, None; Mohamed Mohamed, None; Sonali Nashine, None; Marilyn Chwa, None; Cristina Kenney, None; Baruch Kuppermann, AcuFocus (C), Alcon (C), Alimera (C), Allegro (C), Allergan (C), Allergan (F), Ampio (C), Aqua Therapeutics (C), Bausch and Lomb (C), Genentech (C), Glaukos (C), GlaxoSmithKline (F), Gnenentech (F), Neurotech (C), Novagali (C), Novartis (C), Ophthotech (C), OphthoTech (F), Regeneron (C), Regeneron (F), SecondSight (C), Staar Surgical (C), Teva (C), Thrombogeneics (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3012. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sean W Tsao, Abdul Sami Memon, Sina Abedi, Mohammad Riazi Esfahani, Mohamed Mohamed, Sonali R Nashine, Marilyn Chwa, Cristina M Kenney, Baruch D Kuppermann; Response of ARPE-19 cybrids of European and African origin to high glucose and bevacizumab.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3012.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Oxidative stress and mitochondrial dysfunction have been implicated in the pathway to cell death in diabetic retinopathy. Mitochondrial DNA (mtDNA) can be classified into haplogroups that represent different geographic origins of populations. Differences in maternally inherited mtDNA haplogroups can influence susceptibility to various ocular diseases. The influence of mtDNA haplogroups on mitochondrial metabolism in diabetes is not well characterized. The purpose of this study is to describe the differences in bioenergetic profile between mtDNA from European origin (H haplogroup) and African origin (L haplogroup) when exposed to high glucose and bevacizumab (beva) in vitro.

Methods : Two groups of cytoplasmic hybrids (cybrids) were created by fusing ARPE-19 cells devoid of mtDNA with platelets from donors of either H or L haplogroups. Both groups of cybrids were exposed to: 1) normal glucose only (NG), 2) high glucose only (HG), 3) normal glucose + beva (NG+B) or 4) high glucose + beva (HG+B). Cells were assayed for levels of reactive oxygen species (ROS) using the fluorescent dye 2', 7’-dichlorodihydrofluorescein diacetate, cell viability (CV) measured by MTT assay and mitochondrial membrane potential (ΔΨm) as measured with JC-1 dye kit. Student’s t-test was used to compare mean percent change between sample groups, with the NG only samples set at 100% production or function

Results : The L haplogroup showed a reduction in ROS production with groups NG+B (81.7%, P<0.001) and HG+B (66.6%, P<0.001). The H haplogroup also had a reduction in ROS production, NG+B (76.6%, P<0.001) and HG+B (68.8%, P=<0.001). CV was improved in the NG+B (+46.6%, p<0.001) and HG+B (+29.1%, p=0.001) cultures for the L haplogroup. This positive effect on CV was not seen in the H haplogroup. ΔΨm was significantly reduced in the L haplogroup cultures NG+B (-25.0%, p=0.004) and HG+B (-30.0%, p<0.001), as well as the H haplogroup cultures NG+B (-49.4%, p<0.001) and HG+B (-47.9%, p<0.001).

Conclusions : ROS production was reduced by the addition of beva in both H and L haplogroups. Beva rescued CV in the L haplogroup, but not in the H haplogroup. ΔΨm was significantly reduced by the addition of Beva in both H and L haplogroups. The varied responses between the H (European) and L (African) cybrids to beva may reflect the diversity in mitochondrial response to energy metabolism and cellular damage in different racial populations.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×